Catalyst Wire Dossier Catalyst Wire Dossier

MART1/Melan-A CTL adoptive transfer

· Dana-Farber Cancer Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MART1/Melan-A CTL adoptive transfer, covering 2013-03-01 to 2013-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma [Phase 1]

See pricing